Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

816 results

• ARRIVEIndependent statistical analysis of A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 12,546NCT00501059
• ARTISTSIndependent statistical analysis of Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 228NCT03567291
• AscenD-LBIndependent statistical analysis of Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 91NCT04001517
• Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: Complete Statistical AnalysisIndependent statistical analysis of Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 1/2Results postedn = 9NCT03041324
• Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 48NCT01723514
• Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 61NCT01688739
• ASCLEPIOS IAn independent statistical analysis of ASCLEPIOS I, the phase 3 double-blind comparison of ofatumumab and teriflunomide in relapsing multiple sclerosis, covering the negative binomial relapse-rate analysis, Cox models for pooled disability endpoints,…Phase 3Results postedn = 930NCT02792218
• ASCLEPIOS IIndependent statistical analysis of Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 930NCT02792218
• ASCLEPIOS IIAn independent statistical analysis of ASCLEPIOS II, the phase 3 trial of subcutaneous ofatumumab versus teriflunomide in relapsing multiple sclerosis: negative binomial annualized relapse rate, Cox models for confirmed disability, pooled analyses…Phase 3Results postedn = 955NCT02792231
• Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467584).Phase 3Results postedn = 62NCT00467584
• ASSENTIndependent statistical analysis of Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 56NCT02809118
• Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 183NCT01840410
• Assessing Neuroinflammation in GWI Using MRS: Complete Statistical AnalysisIndependent statistical analysis of Assessing Neuroinflammation in GWI Using MRS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638998).Phase NAResults postedn = 49NCT04638998
• Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 295NCT00848549
• Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 2,021NCT03901534
• Assessment of Dystussia in Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Dystussia in Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02240329).Phase EARLY_1Results postedn = 4NCT02240329
• Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 301NCT02699463
• At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer’s Disease and Their Caregiver’s: Complete Statistical AnalysisIndependent statistical analysis of At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 30NCT04512040
• Atacicept in Subjects With Optic Neuritis: Complete Statistical AnalysisIndependent statistical analysis of Atacicept in Subjects With Optic Neuritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624468).Phase 2Results postedn = 34NCT00624468
• ATHENA-1Independent statistical analysis of A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 768NCT02656875
• ATLANTICIndependent statistical analysis of ATLANTIC (NCT01347580), a randomized phase 4 trial comparing pre-hospital versus in-hospital initiation of ticagrelor in STEMI patients planned for PCI.Phase 4Results postedn = 1,875NCT01347580
• Atomoxetine and Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine and Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00368849).Phase 2Results postedn = 20NCT00368849
• ATTIndependent statistical analysis of Aquatic Treadmill Therapy for Improving Gait, Balance, Fitness and Quality of Life in Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 9NCT00983827
• ATTRibute-CMIndependent statistical analysis of Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 632NCT03860935
• Audiobooks for Hearing Loss App as Auditory Training: Complete Statistical AnalysisIndependent statistical analysis of Audiobooks for Hearing Loss App as Auditory Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04231396).Phase NAResults postedn = 27NCT04231396
• Augmenting Effects of L-DOPS With Carbidopa and Entacapone: Complete Statistical AnalysisIndependent statistical analysis of Augmenting Effects of L-DOPS With Carbidopa and Entacapone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00547911).Phase 1/2Results postedn = 14NCT00547911
• Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS): Complete Statistical AnalysisIndependent statistical analysis of Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS): primary endpoint results, effect estimate with confidence…Phase NAResults postedn = 32NCT00750165
• Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1/2Results postedn = 65NCT02661282
• AutonomyIndependent statistical analysis of A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04619420).Phase 2Results postedn = 523NCT04619420
• AvatarHELPIndependent statistical analysis of Care.Coach Avatars for Improvement of Outcomes in Hospitalized Elders, Including Mitigation of Falls and Delirium: a Multi-Site Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 2Results postedn = 301NCT03832192
• AXIOMATIC-SSPA detailed statistical analysis of AXIOMATIC-SSP, evaluating BMS-986177 in patients with acute ischemic stroke or transient ischemic attack receiving aspirin and clopidogrel, including MCP-Mod dose-response analysis, relative risks, confidence intervals, and safety…Phase 2Results postedn = 2,366NCT03766581
• AZALEA-TIMI 71Complete statistical analysis of AZALEA-TIMI 71, a randomized phase 2 trial comparing abelacimab with rivaroxaban in patients with atrial fibrillation, including bleeding endpoints, hazard ratios, confidence intervals, and statistical methodology.Phase 2Results postedn = 1,287NCT04755283
• Baclofen as a Perioperative Analgesic Adjuvant: Complete Statistical AnalysisIndependent statistical analysis of Baclofen as a Perioperative Analgesic Adjuvant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03720717).Phase 4Results postedn = 34NCT03720717
• Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit: Complete Statistical AnalysisIndependent statistical analysis of Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 84NCT01299025
• Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy: Complete Statistical AnalysisIndependent statistical analysis of Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04658784).Phase NAResults postedn = 72NCT04658784
• Barre Exercise in Parkinson’s: Complete Statistical AnalysisIndependent statistical analysis of Barre Exercise in Parkinson's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06203990).Phase 1Results postedn = 13NCT06203990
• BASICSIndependent statistical analysis of BASICS (NCT01717755), a randomized parallel-group study of intra-arterial treatment in basilar artery thrombosis and related basilar artery occlusive conditions, including its day-90 favourable-outcome endpoint and planned statistical interpretation.Phase NAn = 282NCT01717755
• BAY 0 9867 Cipro Pediatric Use Study (QUIP): Complete Statistical AnalysisIndependent statistical analysis of BAY 0 9867 Cipro Pediatric Use Study (QUIP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00761462).Phase 3Results postedn = 1,029NCT00761462
• Behavior During Experimentally Induced Pain: Complete Statistical AnalysisIndependent statistical analysis of Behavior During Experimentally Induced Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01594528).Phase NAResults postedn = 49NCT01594528
• BELLE-4Independent statistical analysis of A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation: primary endpoint results,…Phase 2/3Results postedn = 416NCT01572727
• BENEFITIndependent statistical analysis of Crossover Comparison of MultiHance and Dotarem: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02070380).Phase 4Results postedn = 179NCT02070380
• Benefit of Assistive Listening Device for Lateralization: Complete Statistical AnalysisIndependent statistical analysis of Benefit of Assistive Listening Device for Lateralization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05072457).Phase NAResults postedn = 10NCT05072457
• BenidipineTRIndependent statistical analysis of Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06808321).Phase NAResults postedn = 1,659NCT06808321
• Benzocaine Gel Toothache Dose-Response Study: Complete Statistical AnalysisIndependent statistical analysis of Benzocaine Gel Toothache Dose-Response Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00474175).Phase 4Results postedn = 577NCT00474175
• Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram: Complete Statistical AnalysisIndependent statistical analysis of Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01925469).Phase 4Results postedn = 30NCT01925469
• BESTIndependent statistical analysis of BEST (NCT02441556), a randomized parallel-group trial comparing endovascular treatment with standard medical therapy for acute basilar artery occlusion, including its modified Rankin Scale endpoint and planned statistical interpretation.Phase NAn = 131NCT02441556
• BESTFITIndependent statistical analysis of BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01903265).Phase 2/3Results postedn = 205NCT01903265
• Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma: Complete Statistical AnalysisIndependent statistical analysis of Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 7NCT00795665
• Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas: Complete Statistical AnalysisIndependent statistical analysis of Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01125046).Phase 2Results postedn = 50NCT01125046
• Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 182NCT01730950

← All therapeutic areas